申请人:UVic Industry Partnerships Inc.
公开号:US20170299606A1
公开(公告)日:2017-10-19
This application relates to methods of quantifying AKT1 and AKT2 and determining AKT1 and AKT2 phosphorylation status. The disclosed methods allow for selection of cancer therapy.